NASDAQ:INCY

Incyte Stock Insider Trading

Healthcare > Biotechnology

Buy INCY

*Your capital is at risk

$97.98

+5.74 (+6.22%)

At Close: Jun 03, 2026

Incyte Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -62.84. In total, the insiders bought 754.56K and sold 443.84K INCY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-62.84
● Buy	754.56K shares
● Sell	443.84K shares
65% Buy Activity Strong Positive Correlation
Buy Signal Low Confidence May 06, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -62.84. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 07, 2026 Sell	Common Stock S-Sale	Issa Mohamed Khairie EVP, Head Of Us Oncology	Officer	10 856 Value: $1.18M
Jan 06, 2026 Sell	Common Stock F-InKind	Issa Mohamed Khairie EVP, Head Of Us Oncology	Officer	8 264 Value: $881.4K
Jan 05, 2026 Sell	Common Stock S-Sale	Stein Steven H EVP & Chief Medical Officer	Officer	15 634 Value: $1.59M
Dec 31, 2025 Buy	Common Stock A-Award	Baker Bros. Advisors Lp	Director	328 Value: $32.4K
Dec 31, 2025 Buy	Common Stock A-Award	Baker Bros. Advisors Lp	Director	328 Value: $32.4K
Dec 31, 2025 Sell	Common Stock F-InKind	Morrissey Michael James EVP, Head Of Tech. Operations	Officer	254 Value: $25.1K
Dec 31, 2025 Sell	Common Stock F-InKind	Stein Steven H EVP & Chief Medical Officer	Officer	13 292 Value: $1.31M
Dec 31, 2025 Buy	Common Stock A-Award	Clancy Paul J Director	Director	241 Value: $23.8K
Dec 31, 2025 Buy	Common Stock A-Award	Harrigan Edmund Director	Director	245 Value: $24.2K
Dec 19, 2025 Buy	Incentive Stock Option (right to buy) M-Exempt	Tray Thomas Principal Accounting Officer	Officer	1 044 Value: $100.0K
Dec 19, 2025 Sell	Common Stock S-Sale	Tray Thomas Principal Accounting Officer	Officer	2 774 Value: $277.4K
Dec 19, 2025 Buy	Common Stock M-Exempt	Tray Thomas Principal Accounting Officer	Officer	1 044 Value: $100.0K
Dec 19, 2025 Buy	Common Stock M-Exempt	Tray Thomas Principal Accounting Officer	Officer	1 730 Value: $165.7K
Dec 19, 2025 Buy	Non-Qualified Stock Option (right to buy) M-Exempt	Tray Thomas Principal Accounting Officer	Officer	1 730 Value: $165.7K
Dec 18, 2025 Sell	Common Stock S-Sale	Tray Thomas Principal Accounting Officer	Officer	600 Value: $59.0K
Dec 17, 2025 Sell	Common Stock S-Sale	Morrissey Michael James EVP, Head Of Tech. Operations	Officer	4 323 Value: $420.5K
Dec 16, 2025 Sell	Common Stock S-Sale	Morrissey Michael James EVP, Head Of Tech. Operations	Officer	53 175 Value: $5.17M
Dec 16, 2025 Sell	Common Stock S-Sale	Morrissey Michael James EVP, Head Of Tech. Operations	Officer	833 Value: $81.2K
Dec 11, 2025 Sell	Common Stock S-Sale	Mayes Patrick A EVP & Chief Scientific Officer	Officer	255 Value: $24.2K
Dec 10, 2025 Sell	Common Stock S-Sale	Mayes Patrick A EVP & Chief Scientific Officer	Officer	5 553 Value: $530.8K
Dec 08, 2025 Sell	Common Stock F-InKind	Hoppenot Herve Director	Director	2 843 Value: $274.9K
Dec 02, 2025 Sell	Common Stock S-Sale	Stein Steven H EVP & Chief Medical Officer	Officer	20 105 Value: $2.06M
Dec 01, 2025 Buy	Common Stock A-Award	Hoffman Richard A. EVP & General Counsel	Officer	9 466 Value: $965.9K
Dec 01, 2025 Buy	Employee Stock Option (right to buy) A-Award	Hoffman Richard A. EVP & General Counsel	Officer	43 301 Value: $4.42M
Dec 01, 2025 Sell	Common Stock S-Sale	Stein Steven H EVP & Chief Medical Officer	Officer	2 559 Value: $263.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT INCYTE CORPORATION

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr...

Read Full Profile Here